To include your compound in the COVID-19 Resource Center, submit it here.
Regenacy Pharmaceuticals LLC (Boston, Mass.) named Simon Jones president and CEO. He was VP of biology at EPIX Pharmaceuticals Inc. (Pink:EPIX). Jones succeeds Walter Ogier, who will remain a director. Last December,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury